78754-94-6

Basic information

• Product Name: 3-CARBOXYMETHYL-QUINAZOLINE-2,4-DIONE
• Synonyms: AKOS BC-0212;3-CARBOXYMETHYL-QUINAZOLINE-2,4-DIONE;RARECHEM EM WB 0254;2-(2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetic acid;3(2H)-Quinazolineacetic acid, 1,4-dihydro-2,4-dioxo-;2-(2,4-diketo-1H-quinazolin-3-yl)acetic acid;2-(2,4-dioxo-1H-quinazolin-3-yl)acetic acid;2-(2,4-dioxo-1H-quinazolin-3-yl)ethanoic acid
• CAS NO: 78754-94-6
• Molecular Formula: C₁₀H₈N₂O₄
• Molecular Weight: 220.18
• Mol File: 78754-94-6.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• Storage Temp.: Store at -15°C
• CAS DataBase Reference: 3-CARBOXYMETHYL-QUINAZOLINE-2,4-DIONE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-CARBOXYMETHYL-QUINAZOLINE-2,4-DIONE(78754-94-6)
• EPA Substance Registry System: 3-CARBOXYMETHYL-QUINAZOLINE-2,4-DIONE(78754-94-6)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• HazardClass: IRRITANT
• Hazardous Substances Data: 78754-94-6(Hazardous Substances Data)

Usage

Chemical Properties

White powder

Upstream product

• 121732-71-6 N-(tert-Butoxycarbonyl)anthraniloyl-glycin-methylester 
• 5973-34-2 (2-aminobenzoylamino)acetic acid ethyl ester 
• 82185-40-8 2-amine-N-(methoxycarbonylmethyl)benzamide 
• 541-41-3 chloroformic acid ethyl ester 
• 118-48-9 isatoic anhydride 
• 82603-69-8 methyl 1,4-dihydro-2,4-dioxoquinazoline-3(2H)-acetate 
• 118-92-3 anthranilic acid 
• 4376-18-5 Monomethyl phthalate 
• 866431-50-7 methyl [(2-{[(benzyloxy)carbonyl]amino}benzoyl)amino]acetate 
• 58004-83-4 (2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-acetic acid ethyl ester 
• 1793-07-3 methyl 2-isocyanatobenzoate 
• 56-40-6 glycine 
• 78754-95-7 2-[3-(2-ethoxy-2-oxoethyl)ureido]benzoic acid 
• 78754-91-3 2-(3-ethoxycarbonylmethylureido)benzonitrile 

Downstream Products

• 20054-80-2 2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-N-phenylacetamide 

Relevant articles and documents

COMPOSITIONS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR 2 (S1PR2) BINDING AGENTS AND USES THEREOF

Described are compounds for the binding of S1PR2, and imaging agents and pharmaceutical compositions including said compounds. Also described are methods employing the compounds, imaging agents, and pharmaceutical compositions. These methods include imaging and/or treatment of diseases associated with S1PR2.

Synthesis, in vivo and in silico anticonvulsant activity studies of new derivatives of 2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)acetamide

In order to expand the arsenal of biologically active substances of anticonvulsive action by the interaction of 2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)acetic acid with the corresponding amines in the presence of N,N′-carbonyldiimidazole in the dioxan

A Series of 2,4(1H,3H)-Quinazolinedione derivatives: Synthesis and biological evaluation as potential anticancer agents

A series of 6,7-disubstituted-3-{2-[4-(substituted)piperazin-1-yl]-2-oxoethyl}quinazoline- 2,4(1H,3H)-dione derivatives (7-34) were synthesized and their structures were elucidated on the basis of analytical and spectral (UV, IR, 1H-NMR, 1